Clin2
NCT06467942Possibly a fitRecruiting

Chinese medicine and probiotics for persistent HPV

Human Papilloma Virus Infection

Part of Infections clinical trials.

This trial tests whether a combination of Chinese medicine and a probiotic (Lactobacillus) can help clear a long-lasting HPV infection. It's for women who have had the same high-risk HPV type for over a year and have not developed serious cervical changes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
240 people
Ages
25 years and older
Study type
Interventional

Who can take part

  • You are a woman over 25 years old.
  • You have had the same high-risk type of HPV for more than 1 year.
  • Your Pap test shows only mild changes (ASC-US or LSIL) or is normal, and your biopsy shows no serious changes.
  • You agree to use contraception during the study.
  • You are willing to take the medicine and follow the study schedule.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05262010Recruiting· Phase 3
HPV vaccine study for Chinese women, ages 9–45

This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.

Hechi, Guangxi
NCT04232917Recruiting· Phase 4
Testing a treatment to help clear genital high-risk HPV

This trial studies 2LPAPI® to see if it helps the body clear high-risk HPV infections in the cervix. It may be an option if you have a current HPV infection with mild/early abnormal cervical findings and can complete follow-up for about a year.

Brussels
NCT07493824Recruiting· Phase 4
Study of Paiteling Antibacterial Liquid for Persistent HPV Infection

This trial tests an antibacterial liquid (Paiteling®) to see if it can clear a persistent high-risk HPV infection of the cervix. It may be an option for women whose HPV has lasted 2 years or more and whose cervical biopsy shows only mild changes.

Changchun, Jilin
NCT07785843Not yet recruiting· Phase 3
HPV Vaccine Study for Chinese Women with or without Prior Cervarix

This study tests a new HPV vaccine (V503, known as Gardasil 9) in Chinese women who either previously received the bivalent HPV vaccine (Cervarix) more than a year ago or never had any HPV vaccine. The goal is to see if this vaccine can effectively prevent HPV-related diseases.

NCT07572396Recruiting· Phase 2
HPV treatment with vaginal suppositories for mild cervical changes

This study tests a new vaginal medication (Dysplasix) to treat mild cervical cell changes caused by high-risk HPV. The goal is to see if this treatment can help your body clear the virus and prevent these changes from getting worse.

Shatin, New Territories
NCT04422366Recruiting· Phase 3
9-valent HPV vaccine study for healthy Chinese women

This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.

Liuzhou, Guangxi

Hear when a new Human Papilloma Virus Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.